Stockhub

Hugel, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

21 September 2022

  • curprev 10:4610:46, 21 September 2022 95.149.241.133 talk 1,153 bytes +1,153 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Hugel, Inc. operates as a biopharmaceutical company in South Korea and internationally. It offers Botulinum Toxin, a white injectable dry powder in a transparent glass vial for use in the treatment of positive essential eyelid convulsion in adults over 18 years of age; improvement of severe lasso wrinkles associated with corrugator muscles and/or procerus muscle activities in adults aged between 18 and 65; treatment of uppe..."
Retrieved from "https://stockhub.co/research/Hugel,_Inc."